Bio-Techne (TECH) Total Current Liabilities (2010 - 2026)

Bio-Techne's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $153.3 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 9.41% year-over-year to $153.3 million in Q1 2026; TTM through Mar 2026 was $153.3 million, a 9.41% decrease from a year earlier, with the FY2025 full-year figure at $175.8 million, up 10.33% from the prior year.
• Total Current Liabilities advanced to $153.3 million in Q1 2026 per TECH's latest filing, from $140.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $176.0 million in Q2 2022 and bottomed at $127.8 million in Q3 2023.
• The 5-year median for Total Current Liabilities is $144.5 million (2025), against an average of $149.3 million.
• Across the five-year window, Total Current Liabilities retreated 26.99% in 2023 and climbed 24.02% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $128.4 million in 2022, then gained by 5.32% to $135.2 million in 2023, then increased by 19.24% to $161.3 million in 2024, then retreated by 12.92% to $140.4 million in 2025, then advanced by 9.15% to $153.3 million in 2026.
• Per Business Quant, the three latest TECH Total Current Liabilities figures stand at $153.3 million (Q1 2026), $140.4 million (Q4 2025), and $144.5 million (Q3 2025).